Search Results - "Adam, Heather"

Distribution and antimicrobial susceptibility profile of pathogens recovered from the bloodstream of Canadian patients: results from the CANWARD study (2007–23).

Authors: Walkty, Andrew Adam, Heather J Baxter, Melanie et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2025 Supplement, Vol. 80, pii72-ii82. 11p.

Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007–23).

Authors: Adam, Heather J Golden, Alyssa R Martin, Irene et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2025 Supplement, Vol. 80, pii35-ii44. 10p.

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–21 Open Access

Authors: Schellenberg, John J Adam, Heather J Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). May2025, Vol. 80 Issue 5, p1377-1385. 9p.

Seventeen years of the CANWARD study (2007–23).

Authors: Zhanel, George G Adam, Heather J

Source: Journal of Antimicrobial Chemotherapy (JAC). 2025 Supplement, Vol. 80, pii2-ii4. 3p.

This result is not displayed to guests.
Login for full access.

Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21.

Authors: Schellenberg, John J Adam, Heather J Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Oct2024, Vol. 79 Issue 10, p2653-2661. 9p.

'Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–2021-right-to-reply'

Authors: Schellenberg, John J Adam, Heather J Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Apr2026, Vol. 81 Issue 4, p1-1. 1p.

Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.

Authors: Zhanel, George G. Mansour, Celine Mikolayanko, Stacey et al.

Source: Drugs. Oct2024, Vol. 84 Issue 10, p1219-1250.

Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20.

Authors: Schellenberg, John J Adam, Heather J Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2023 Supplement, Vol. 78, pi37-i47. 11p.

Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020.

Authors: Golden, Alyssa R Adam, Heather J Karlowsky, James A et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2023 Supplement, Vol. 78, pi26-i36. 11p.

Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020.

Authors: Adam, Heather J Karlowsky, James A Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2023 Supplement, Vol. 78, pi17-i25. 9p.

Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007–2018.

Authors: Golden, Alyssa R. Adam, Heather J. Baxter, Melanie et al.

Source: Vaccine. Sep2021, Vol. 39 Issue 39, p5474-5483. 10p.

Enterococcus faecium harbouring vanA , optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.

Authors: McCracken, Melissa Lerminiaux, Nicole Adam, Heather J et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Feb2026, Vol. 81 Issue 2, p1-5. 5p.

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).

Authors: Zhanel, George G Adam, Heather J Baxter, Melanie et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Jul2021, Vol. 76 Issue 7, p1808-1814. 7p.

Nontoxigenic Vibrio cholerae Septicemia in an Immunocompromised Patient.

Authors: Kadkhoda, Kamran Adam, Heather Gilmour, Matthew W. et al.

Source: Case Reports in Infectious Diseases. 2012, p1-3. 3p.

Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.

Authors: Karlowsky, James A Adam, Heather J Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). Jul2020, Vol. 75 Issue 7, p1824-1832. 9p.

Characterization of MRSA in Canada from 2007 to 2016.

Authors: Nichol, Kimberly A Adam, Heather J Golding, George R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2019 Supplement, Vol. 74, piv55-iv63. 9p.

Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study.

Authors: McCracken, Melissa G Adam, Heather J Blondeau, Joseph M et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2019 Supplement, Vol. 74, piv32-iv38. 7p.

Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007–16.

Authors: Lagacé-Wiens, Philippe R S Adam, Heather J Poutanen, Susan et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2019 Supplement, Vol. 74, piv22-iv31. 10p.

42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study.

Authors: Zhanel, George G Adam, Heather J Baxter, Melanie R et al.

Source: Journal of Antimicrobial Chemotherapy (JAC). 2019 Supplement, Vol. 74, piv5-iv21. 17p.